Published in
American Chemical Society, Journal of Medicinal Chemistry, 21(64), p. 16159-16176, 2021
DOI: 10.1021/acs.jmedchem.1c01437
Links
Tools
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
Journal article published in 2021 by
Charles E. Mowbray 
,
Stéphanie Braillard,
Paul A. Glossop ,
Gavin A. Whitlock,
Robert T. Jacobs ,
Jason Speake,
Bharathi Pandi,
Bakela Nare,
Louis Maes,
Vanessa Yardley,
Yvonne Freund,
Richard J. Wall ,
Sandra Carvalho,
Davide Bello,
Magali Van den Kerkhof
and other authors.
,
Stéphanie Braillard,
Paul A. Glossop ,
Gavin A. Whitlock,
Robert T. Jacobs ,
Jason Speake,
Bharathi Pandi,
Bakela Nare,
Louis Maes,
Vanessa Yardley,
Yvonne Freund,
Richard J. Wall ,
Sandra Carvalho,
Davide Bello,
Magali Van den Kerkhof
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 